Personalized regulation of glioblastoma cancer stem cells based on biomedical technologies: From theory to experiment (Review)

International Journal of Molecular Medicine
Igor S BryukhovetskiyYuri S Khotimchenko

Abstract

Glioblastoma multiforme (GBM) is one of the most aggressive brain tumors. GBM represents >50% of primary tumors of the nervous system and ~20% of intracranial neoplasms. Standard treatment involves surgery, radiation and chemotherapy. However, the prognosis of GBM is usually poor, with a median survival of 15 months. Resistance of GBM to treatment can be explained by the presence of cancer stem cells (CSCs) among the GBM cell population. At present, there are no effective therapeutic strategies for the elimination of CSCs. The present review examined the nature of human GBM therapeutic resistance and attempted to systematize and put forward novel approaches for a personalized therapy of GBM that not only destroys tumor tissue, but also regulates cellular signaling and the morphogenetic properties of CSCs. The CSCs are considered to be an informationally accessible living system, and the CSC proteome should be used as a target for therapy directed at suppressing clonal selection mechanisms and CSC generation, destroying CSC hierarchy, and disrupting the interaction of CSCs with their microenvironment and extracellular matrix. These objectives can be achieved through the use of biomedical cellular products.

References

Nov 9, 2000·Proceedings of the National Academy of Sciences of the United States of America·K S AboodyE Y Snyder
Mar 10, 2006·Neuro-oncology·Karen S AboodyGeorge Perides
Dec 8, 2006·Nature·Peter B Dirks
Jul 10, 2007·Acta Neuropathologica·David N LouisPaul Kleihues
Jul 30, 2008·Cell·Joan Massagué
Aug 7, 2008·PloS One·Anne-Pierre MorelAlain Puisieux
Sep 24, 2009·Biochemistry·Minyong ChenWei Chen
Sep 25, 2009·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Christophe Mariette
Jul 31, 2010·The American Journal of Pathology·Eli E BarCharles G Eberhart
Jun 15, 2011·Cell Cycle·Peter DuesbergJoshua M Nicholson
Aug 23, 2011·International Journal of Cancer. Journal International Du Cancer·Javier MercapideAurelio Lorico
Aug 16, 2012·Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progrès Dans Les Recherches Sur Le Cancer·Melania DovizioPaola Patrignani
Jan 10, 2013·PloS One·Javier MercapideAurelio Lorico
Feb 20, 2013·Cancer Letters·Mark KatakowskiMichael Chopp
Mar 9, 2013·International Journal of Medical Sciences·Pengcheng LiHualiang Xiao
May 10, 2013·Science Translational Medicine·Karen S AboodyJana Portnow
Jun 12, 2013·Biochimie·Ludovic ZimmerlinAlbert D Donnenberg
Aug 3, 2013·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Anja WielandBjörn Scheffler
Oct 10, 2013·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Seung Ah ChoiSeung-Ki Kim
Nov 7, 2013·JAMA : the Journal of the American Medical Association·Antonio Omuro, Lisa M DeAngelis
Nov 13, 2013·Cell Biochemistry and Biophysics·Haidong XuQiang Fu
Jan 1, 2012·Pharmaceuticals·Melania DovizioPaola Patrignani
Feb 8, 2014·Methods in Molecular Biology·Richard T Jennings, Ulla G Knaus
Feb 21, 2014·Molecular Cancer Therapeutics·Angelina I Londoño-JoshiDonald J Buchsbaum
Apr 17, 2014·Gynecologic Oncology·Rebecca C ArendDonald J Buchsbaum
Apr 18, 2014·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Chengfei LiuAllen C Gao
Apr 23, 2014·The Neuroradiology Journal·Rossella RispoliSandro Carletti
May 21, 2014·Cancer Science·Yutaka KondoKeiko Shinjo
Jul 6, 2014·Brain Pathology·David N LouisUNKNOWN International Society Of Neuropathology--Haarlem
Jul 24, 2014·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Jigisha P ThakkarJohn L Villano

❮ Previous
Next ❯

Citations


❮ Previous
Next ❯

Methods Mentioned

BETA
flow cytometry
electron microscopy
GTPase

Related Concepts

Related Feeds

Cancer Stem Cells in Glioblastoma

Glioblastoma is the most common and aggressive type of brain tumor. It contains a population of tumor initiating stem cell-like cells known as cancer stem cells. Investigations are ongoing into these cancer stem cells found in these solid tumors which are highly resistance to treatment. Here is the latest research on cancer stem cells in glioblastoma.